Secondary Data Analysis of Patients at Risk for CKD to Inspect CKD Prevalence, Diagnosis Rates, Diagnostic Behaviour, Treatment Patterns and Patient Characteristics

CompletedOBSERVATIONAL
Enrollment

800,211

Participants

Timeline

Start Date

July 26, 2023

Primary Completion Date

September 30, 2023

Study Completion Date

September 30, 2023

Conditions
Chronic Kidney Diseases
Trial Locations (1)

Unknown

Research Site, Koblenz

Sponsors

Lead Sponsor

All Listed Sponsors
lead

AstraZeneca

INDUSTRY